Mesoamerican nephropathy

Mesoamerican nephropathy (MeN) is a currently unexplained epidemic of chronic kidney disease of unknown origin (CKDu),[1] prevalent in the Pacific Ocean coastal low lands of the Mesoamerican region, including southern Mexico, Guatemala, El Salvador, Nicaragua, Honduras and Costa Rica. In rural areas of Nicaragua the disease is colloquially called creatinina.[2]

Mesoamerican nephropathy
Other namesCreatinina
SpecialtyNephrology

This CKD epidemic in Central America spans along a nearly 1000 kilometer stretch of the Pacific coast. In El Salvador and Nicaragua alone, the reported number of men dying from this painful disease has risen five-fold in the last 20 years, although some researchers believe hidden cases have always been there and this increment in official data could be partially due to the recent increase in reports and improved case search, pushed by the growing social and political interest in the disease. In El Salvador, the disease has become the second leading cause of death among adult men, and according to a recent editorial,[3] it has been estimated that this largely unknown epidemic has caused the premature death of at least 20,000 men in the region.[4] Science Magazine reports: "In El Salvador alone, PAHO's latest figures say CKD of all causes kills at least 2,500 people in the country each year".[5][6]

The people affected by the epidemic are mainly young and middle-aged male laborers in the agricultural sector,[7][8] particularly sugarcane workers.[9][10] The disease has also been found to be prevalent in other occupations with a high risk of heat stress, implying strenuous work (miners, construction, port and transportation workers)[9][10][11][12][13] in the high temperatures of the coastlands. The epidemic appears to affect particular Pacific coastal regions of Nicaragua,[9][11][13] El Salvador,[7][10][14] Costa Rica,[15][16] and Guatemala.

Causes

The cause of MeN is unclear, but it is certainly not explained by conventional causes such as diabetes mellitus or hypertension.[1][7] The cause of MeN is uncertain but many risk factors have been proposed, including repeated episodes of heat stress, dehydration, and long hours of work labor. [17]

Multifactorial disease

The above-mentioned declaration produced by the April 2013 International Conference which took place in San Salvador said that:

“While there is consensus that this is a multifactorial disease, some of the main factors include exposure to agrochemicals, either through direct prolonged exposure over time or through residual long-standing contamination of the soil, water sources, and crops, compounded by difficult working conditions; exposure to high temperatures; and insufficient water intake, among others factors.”

The nature of multifactorial problems is, that the observed disease can be caused from regionally different sets of risk factors, e.g. agrochemicals and heavy metals are ubiquitous in endemic and non-endemic areas, feature proteinuria, or have not been related previously to CKD but only to acute kidney injury. Mesoamerican volcanic soils, for instance, are rich in arsenic and cadmium (e.g. CKDu miners).

Alcoholism and self-medication

Alcoholism and self-medication are also common features in these populations. NSAIDs self-prescription is particularly widespread,[18][19] possibly due to frequent agricultural work posture-related pains, and dysuria is commonly treated with aminoglycosides, often not related to urinary tract infections but perhaps associated with dehydration itself.[18]

Clinical manifestations

Clinical manifestations,[10][14][20][21][22] and biopsy findings[21][23] suggest MeN could be a new form of CKD, a new pathologic entity related to repeated heat stress, dehydration, salt depletion, and possibly other contributing factors, like NSAIDs abuse.[1][3][4][12][20][21][24][25][26][27][28][29][30][31] A recent study[32] with Wild-type mice exposed to recurrent dehydration induced by heat stress produced a similar pattern of kidney injury, thus providing a potential mechanism for MeN, by activation of the polyol pathway, via metabolism by fructokinase, resulting in generation of endogenous fructose and uric acid in the kidney that subsequently induces renal injury.

Heatstress and dehydration

The same position supported by the authors of one study developed in El Salvador,[19] but the El Salvadoran study did not find an increased odds ratio for CKD in people exposed to agrochemical products, or direct evidence linking it to pesticides. Other studies from Sri Lanka have showed that chronic exposure of people in agrochemically laden fields to low levels of cadmium through the food chain and also to pesticides could be responsible for significantly higher urinary excretion of cadmium in individuals with CKDu,[33] but urinary cadmium excretion is increased in all forms of CKD, and cadmium nephropathy is highly proteinuric while MeN is not. Based on that hypothetical possibility, Sri Lanka has banned many of these chemicals, and El Salvador has similar legislation pending,[34] waiting for direct evidence linking the disease to the use of agrochemicals in the Mesoamerican region. A large (nearly 38,000 workers, 5 year follow up) prospective study from Thailand in 2012[35] found a 5-fold increased risk (adjusted odds ratio) for CKD in heat stress exposed workers with physical jobs, so the disease could be more prevalent around the globe than first thought, and needs a closer look. The heat stress hypothesis needs to be more deeply considered and examined.

Published evidence in 2016 suggest heat stress and strenuous activity-induced cyclic uricosuria and crystalluria as a possible mechanism for the tubular lesion.[20][24][25]

Agrochemicals

A relationship between CKDu and people working in agriculture can be found in El Salvador in areas with high pesticide use.[36] The study did not find a direct cause for the etiology, but nephrotoxic environmental factors cannot be ruled out. In a rural area in Sri Lanca a possible association between CKD and a long term low- level exposure to OP pesticides was detected.[37] In a Latin American country high creatinine levels of workers can likely be attributed to the use of the nematicide DBCP.[38] Also a relationship between increased blood levels of certain organochlorine pesticides and the occurrence of chronic kidney disease was observed in India.[39] In Nicaragua a non significant relation between pesticide use and the occurrence of CKDu was observed. The occurrence of CKDu was higher in person groups exposed to pesticides than in the control group.[40]

The import and production of agrochemicals can be quantified. In addition to the amount of agrochemicals the workflow in which agrochemicals are applied are relevant for the exposure of workers to agrochemical (application with tractor or manual work or application of self-protection measures). CKDu has not been reported among workers laboring under supposedly similar heat stress in other tropical areas of the world, such as Brazil, Cuba or Jamaica, where the same pesticides may not have been used in the same fashion or quantities as in Mesoamerica. However, heat stress measurements have not been assessed in these countries and cannot be compared, and CKD cases could be underreported, just like in the Mesoamerican region before the first description of the disease back in 2002. In any case, there are important differences between these Caribbean and Atlantic countries and the Mesoamerican Pacific coastlands, differences including

  • level of agroindustrial mechanization,
  • working conditions (access to drinking water and rest in shady spots),
  • easy access to NSAIDs without prescription,
  • and healthcare accessibility, and
  • marked ethnic differences - because the Mesoamerican Pacific Ocean coastland has little or no black ethnicity influence, being mainly Native American "mestizos".

A large (nearly 38,000 workers, 5 year follow up) prospective study of occupational heat stress and Kidney Disease from Thailand in 2012[35] found a 5-fold increased risk (adjusted odds ratio) for CKD in heat stress exposed workers with physical jobs, so the disease could be more prevalent around the globe than first thought, and needs a closer look. The heat stress hypothesis needs to be more deeply considered and examined as contributing risk factor.

Diagnosis

A comprehensive review of the disease and its characteristics was published in the American Journal of Kidney Diseases in January 2014, describing it as "a medical enigma yet to be solved".[1]

MeN is silent during initial stages but appears to progress quite fast to end-stage renal disease; it is mainly prevalent in young and middle aged men, with rates varying from 1:3 to 1:10 when compared to women,[7][9][10] and has not been described in children. Only dysuria has been reported as an occasional early symptom of the disease.

The disease is only prevalent in the Pacific Ocean's coastal lowlands, absent from coffee plantations at higher grounds.[10][41] Also, agricultural communities located at sea level in the coastlands have an 8 to 10 times greater risk (odds ratio) for presenting the disease, when compared to other agricultural communities working the same type of crops, but located at higher altitudes, away from the coastal low lands.[10][14][20]

Clinically, MeN presents as a tubular-interstitial disease: patients have low-range or no proteinuria,[9][10][11][13][14] electrolyte abnormalities -mainly low serum potassium and sodium-, and high levels of uric acid, but no hypertension.[7][10][14][21][20][42] Also, many patients show uricosuria, and urate crystals are seen on fresh urine samples.[20][24]

Histopathological findings of the disease include tubular atrophy, interstitial fibrosis, and global glomerulosclerosis, a curious finding considering the absence of important proteinuria.[21][23]

Summary of current scientific evidence

To date, CKDu (MeN) causes remain undetermined and debatable; nevertheless the number of cases could lead to the application of a precautionary principles from a humanitarian perspective. Due to the fact that the Mesoamerican nephropathy is regarded as a multifactorial disease the experimental design of comparative study should take following logical setting into account. Multifactorial problem. Assume that a disease is definitely caused by A, B, C and this example has no irrelevant risk factor for the disease. The disease will develop if at least 2 risk factors are present in a certain region.

  • no prevalence of disease in region 1
  • A no prevalence of disease in region 2
  • B no prevalence of disease in region 3
  • C no prevalence of disease in region 4
  • A, B prevalence of disease in region 5
  • B, C prevalence of disease in region 6
  • C, A prevalence of disease in region 7
  • A, B, C prevalence of disease in region 8

Removing the risk factor A in the experimental group in comparison to control group will lead to changes in the outbreak of the disease in only 2 of 8 combinatorically possible regions, even if we define A as a relevant risk factor in this theoretical setting. The same is true if the experimental design adds in a comparative study the risk factor A to the regions in the experimental group in comparison to the control group. Because of the nature of a multifactorial disease, a single factor experimental design (e.g. "C") for one of the mentioned risk factors A, B and C will create a systematic underestimation of the risk for a single risk factor (e.g. "C") in this deterministic setting with relevant risk factors A, B and C only. Therefore the exclusion of a risk factor (e.g. "C") by not finding the evidence in the single factor experimental design cannot be performed even in a non-deterministic setting with uncertainties and irrelevant risk factors for the considered disease.

If the difference in experimental and control are 2 risk factors (adding or removing two risk factor e.g. A, B in the control group), then 4 regions will show a differences in prevalence of the disease, with the disadvantage that the experimental design cannot clarify if one or both risk factors A and B are contributing to the progression and prevalence of the disease. The precautionary principles could lead to risk mitigation strategies for risk factor A and B until the etiology is clarified.

Beside this logical analysis of a multifactorial setting there is space for further investigation, e.g.: Leptospirosis has been suggested as a possible contributing factor[1][43][44] and oceanic nephrotoxic algae.

Risk factors associated with agents need evidence for the nephrotoxicity of the agent and evidence for the exposure assessment of a cohort to the risk factor. Assessment of the mentioned risk factors and their possible synergism will depend on more and better research.

History

The real timeline of the disease is unknown since most of the aforementioned countries did not have or still lack renal disease registries, and the affected regions are mainly poor farm lands. Nicaraguan health authorities have commented that they have been noting an increase of CKD cases in the Pacific Ocean coastal regions since the 80s, but it was not until 2002 that a scientific paper from an El Salvadoran reference hospital[7] first communicated and described the existence of an important group of CKDu patients with a particular epidemiological pattern. In January 2005, a second scientific paper,[14] also from El Salvador, reported some field efforts on trying to identify the cause of the disease, and confirmed its curious epidemiological pattern.

In April 2013, a high-level meeting with regional health ministries, nongovernmental organizations, aid agencies, clinical specialists and researchers was held in San Salvador city, El Salvador, leading the Panamerican Health Organization (PAHO) to finally declare CKDu "a pressing and extremely serious health problem in the region". The Declaration described CKD as having “catastrophic effects associated with toxic-environmental and occupational factors, dehydration and behaviors harmful to renal health". In it, the Ministers of Health of the Central American Integration System [SICA, the Spanish acronym] declared their commitment to address CKDu comprehensively and to “strengthening scientific research in the framework of the prevention and control of chronic non-communicable diseases.”[45] This Declaration was subsequently endorsed by PAHO through the Resolution CD52.R1, adopted during the 52nd Directing Council, 65th Session of the Regional Committee of WHO for the Americas, in October 2013.[46]

In November 2015, a second CENCAM workshop was held in San Jose, Costa Rica. A statement and a report are under the works.

See also

References
  1. Correa-Rotter R, Wesseling C, Johnson RJ (March 2014). "CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy". Am J Kidney Dis. 63 (3): 506–20. doi:10.1053/j.ajkd.2013.10.062. PMC 7115712. PMID 24412050.
  2. Landau, Elizabeth (June 11, 2014). "Mysterious kidney disease plagues Central America". CNN. Retrieved 13 June 2014.
  3. Wesseling C, Crowe J, Hogstedt C, Jakobsson K, Lucas R, Wegman DH (November 2013). "The epidemic of chronic kidney disease of unknown etiology in Mesoamerica: a call for interdisciplinary research and action". Am J Public Health. 103 (11): 1927–30. doi:10.2105/AJPH.2013.301594. PMC 3828726. PMID 24028232.
  4. Ramirez-Rubio O, McClean MD, Amador JJ, Brooks DR (January 2013). "An epidemic of chronic kidney disease in Central America: an overview". J Epidemiol Community Health. 67 (1): 1–3. doi:10.1136/jech-2012-201141. PMID 23002432.
  5. Cohen, J. (April 2014). "Mesoamerica's Mystery Killer". Science. 344 (6180): 143–47. doi:10.1126/science.344.6180.143. PMID 24723592.
  6. Phelan M, Linton M (April 2014). "Science Magazine: Researchers Hunt Origin of an Enigmatic Kidney Disease". Cite journal requires |journal= (help)
  7. García-Trabanino R, Aguilar R, Reyes Silva C, Ortiz Mercado M, Leiva Merino R (September 2002). "[End-stage renal disease among patients in a referral hospital in El Salvador]". Rev Panam Salud Publica. 12 (3): 202–06. doi:10.1590/s1020-49892002000900009. PMID 12396639.
  8. Sanoff SL, Callejas L, Alonso CD, Hu Y, Colindres RE, Chin H, Morgan DR, Hogan SL (2010). "Positive association of renal insufficiency with agriculture employment and unregulated alcohol consumption in Nicaragua". Ren Fail. 32 (7): 766–77. doi:10.3109/0886022X.2010.494333. PMC 3699859. PMID 20662688.
  9. Torres C, Aragón A, González M, López I, Jakobsson K, Elinder CG, Lundberg I, Wesseling C (March 2010). "Decreased kidney function of unknown cause in Nicaragua: a community-based survey". Am J Kidney Dis. 55 (3): 485–96. doi:10.1053/j.ajkd.2009.12.012. PMID 20116154.
  10. Peraza S, Wesseling C, Aragon A, Leiva R, Garcia-Trabanino R, Torres C, Jakobsson K, Elinder CG, Hogstedt C (April 2012). "Decreased kidney function among agricultural workers in El Salvador". Am J Kidney Dis. 59 (4): 531–40. doi:10.1053/j.ajkd.2011.11.039. PMID 22300650.
  11. O'Donnell JK, Tobey M, Weiner DE, Stevens LA, Johnson S, Stringham P, Cohen B, Brooks DR (September 2011). "Prevalence of and risk factors for chronic kidney disease in rural Nicaragua". Nephrol Dial Transplant. 26 (9): 2798–805. doi:10.1093/ndt/gfq385. PMC 4592358. PMID 20615905.
  12. Brooks DR, Ramirez-Rubio O, Amador JJ (April 2012). "CKD in Central America: a hot issue". Am J Kidney Dis. 59 (4): 481–84. doi:10.1053/j.ajkd.2012.01.005. PMID 22444491.
  13. McClean MD, Amador J, Laws R, et al. (2012). "Biological sampling report: Investigating biomarkers of kidney injury and chronic kidney disease among workers in Western Nicaragua" (PDF). Cite journal requires |journal= (help)
  14. García-Trabanino R, Domínguez J, Jansà JM, Oliver A (January 2005). "[Proteinuria and chronic renal failure in the coast of El Salvador: detection with low cost methods and associated factors]". Nefrologia. 25 (1): 31–8. PMID 15789534.
  15. Cerdas M. (August 2005). "Chronic kidney disease in Costa Rica". Kidney Int Suppl. 97 (S): 31–35. doi:10.1111/j.1523-1755.2005.09705.x. PMID 16014096.
  16. Wesseling C. (June 2014). "Mesoamerican nephropathy in Costa Rica: Geographical distribution and time trends of chronic kidney disease mortality between 1970 and 2012" (PDF). Occup Environ Med. 72 (10): 714–21. doi:10.1136/oemed-2014-102799. PMID 26199395.
  17. Peraza, S., et al.(2012). Decreased Kidney Function Among Agricultural Workers in El Salvador. American Journal of Kidney Diseases, DOI: 10.1053/j.ajkd.2011.11.039
  18. Ramirez-Rubio O, Brooks DR, Amador JJ, Kaufman JS, Weiner DE, Scammell MK (April 2013). "Chronic kidney disease in Nicaragua: a qualitative analysis of semi-structured interviews with physicians and pharmacists". BMC Public Health. 13 (1): 350. doi:10.1186/1471-2458-13-350. PMC 3637184. PMID 23590528.
  19. Orantes CM, Herrera R, Almaguer M, et al. (October 2011). "Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa study, 2009" (PDF). MEDICC Rev. 13 (4): 14–22. PMID 22143603.
  20. García-Trabanino R, Jarquín E, Wesseling C, Johnson RJ, González-Quiroz M, Weiss I, Glaser J, Vindell JJ, Stockfelt L, Roncal C, Harra T, Barregard L (October 2015). "Heat stress, dehydration, and kidney function in sugarcane cutters in El Salvador – a cross-shift study of workers at risk of Mesoamerican nephropathy". Environ Res. 142 (1): 746–55. Bibcode:2015ER....142..746G. doi:10.1016/j.envres.2015.07.007. PMID 26209462.
  21. Wijkström J, Leiva R, Elinder CG, Leiva S, Trujillo Z, Trujillo L, Söderberg M, Hultenby K, Wernerson A (November 2013). "Clinical and Pathological Characterization of Mesoamerican Nephropathy: A New Kidney Disease in Central America". Am J Kidney Dis. 62 (5): 908–18. doi:10.1053/j.ajkd.2013.05.019. PMID 23850447.
  22. Trujillo L, Cruz Z, Leiva R, Lazo S, Cruz V. Clinical characteristics and 3 year follow-up of patient with chronic kidney disease who live in Santa Clara sugarcane cooperative, department of La Paz, El Salvador. In: Wesseling C, Crowe J, Hogstedt C, Jakobsson K, Lucas R, Wegman D, eds. Mesoamerican Nephropathy: Report From the First International Research Workshop on MeN. Heredia, Costa Rica: SALTRA/IRET-UNA; 2013:209–10. http://www.saltra.una.ac.cr/index.php/sst-vol-10. Accessed April 13, 2014.
  23. Lopez-Marin L, Chavez Y, Garcia XA, Flores WM, Garcia YM, Herrera R, Almaguer M, Orantes CM, Calero D, Bayarre HD, Amaya JC, Magana S, Espinoza PA, Serpas L (April 2014). "Histopathology of chronic kidney disease of unknown etiology in Salvadoran agricultural communities". MEDICC Rev. 16 (2): 49–54. PMID 24878649.
  24. Roncal-Jimenez C, García-Trabanino R, Barregard L, Lanaspa MA, Wesseling C, Harra T, Aragon A, Grases F, Jarquin ER, González MA, Weiss I, Glaser J, Sánchez-Lozada LG, Johnson RJ (January 2016). "Heat Stress Nephropathy From Exercise-Induced Uric Acid Crystalluria: A Perspective on Mesoamerican Nephropathy". Am J Kidney Dis. 67 (1): 20–30. doi:10.1053/j.ajkd.2015.08.021. PMID 26455995.
  25. Roncal-Jimenez CA, García-Trabanino R, Wesseling C, Johnson RJ (January 2016). "Mesoamerican Nephropathy or Global Warming Nephropathy?". Blood Purif. 41 (1–3): 135–38. doi:10.1159/000441265. PMID 26766409.
  26. Tangri N (29 July 2013). "MesoAmerican Nephropathy: A New Entity". eAJKD. National Kidney Foundation.
  27. Johnson RJ, Sánchez-Lozada LG (October 2013). "Chronic kidney disease: Mesoamerican nephropathy – new clues to the cause". Nat Rev Nephrol. 9 (10): 560–61. doi:10.1038/nrneph.2013.174. PMID 23999393.
  28. Wesseling C, Crowe J, Hogstedt C, Jakobsson K, Lucas R, Wegman DH; on behalf of the participants of the First International Research Workshop on the Mesoamerican Nephropathy. (March 2014). "Resolving the Enigma of the Mesoamerican Nephropathy: A Research Workshop Summary". Am J Kidney Dis. 63 (3): 396–404. doi:10.1053/j.ajkd.2013.08.014. PMID 24140367.CS1 maint: multiple names: authors list (link)
  29. Weiner DE, McClean MD, Kaufman JS, Brooks DR (March 2013). "The Central American Epidemic of CKD". Clin J Am Soc Nephrol. 8 (3): 504–11. doi:10.2215/CJN.05050512. PMID 23099656.
  30. Wernerson A, Wijkström J, Elinder CG (May 2014). "Update on endemic nephropathies". Curr Opin Nephrol Hypertens. 23 (3): 232–38. doi:10.1097/01.mnh.0000444911.32794.e7. PMID 24717833.
  31. Lucas RA, Bodin T, García-Trabanino R, Wesseling C, Glaser J, Weiss I, Jarquin E, Jakobsson K, Wegman DH (2015). "Heat stress and workload associated with sugarcane cutting – an excessively strenuous occupation!". Extrem Physiol Med. 4 (Suppl 1): A23. doi:10.1186/2046-7648-4-S1-A23. PMC 4580831.
  32. Roncal Jimenez CA, Ishimoto T, Lanaspa MA, Rivard CJ, Nakagawa T, Ejaz AA, Cicerchi C, Inaba S, Le M, Miyazaki M, Glaser J, Correa-Rotter R, González MA, Aragón A, Wesseling C, Sánchez-Lozada LG, Johnson RJ (December 2013). "Fructokinase activity mediates dehydration-induced renal injury". Kidney Int. 86 (2): 294–302. doi:10.1038/ki.2013.492. PMC 4120672. PMID 24336030.
  33. Jayatilake, Nihal; Mendis, Shanthi; Maheepala, Palitha; Mehta, Firdosi R (2013). "Chronic kidney disease of uncertain aetiology: prevalence and causative factors in a developing country". BMC Nephrology. 14 (1): 180. doi:10.1186/1471-2369-14-180. PMC 3765913. PMID 23981540.
  34. Sasha Chavkin (11 April 2014). "Herbicide ban on hold in Sri Lanka, as source of deadly kidney disease remains elusive". The Center for Public Integrity. Retrieved 3 September 2014.
  35. Benjawan Tawatsupa, Lynette L-Y Lim, Tord Kjellstrom, Sam-ang Seubsman, Adrian Sleigh, and the Thai Cohort Study Team (May 2012). "Association Between Occupational Heat Stress and Kidney Disease Among 37 816 Workers in the Thai Cohort Study (TCS)". J Epidemiol. 22 (3): 251–60. doi:10.2188/jea.JE20110082. PMC 3798627. PMID 22343327.CS1 maint: multiple names: authors list (link)
  36. Orantes, C. M., Herrera, R., Almaguer, M., Brizuela, E. G., Hernández, C. E., Bayarre, H., ... & Velázquez, M. E. (2011). Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa study, 2009. MEDICC review, 13, 14-22.
  37. Peiris-John, R., Wanigasuriya, J. K. P., Wickremasinghe, A. R., Dissanayake, W. P., & Hittarage, A. (2006). Exposure to acetylcholinesterase-inhibiting pesticides and chronic renal failure.
  38. Yearout, R., Game, X., Krumpe, K., & McKenzie, C. (2008). Impacts of DBCP on participants in the agricultural industry in a third world nation (an industrial health, safety case study of a village at risk). International Journal of Industrial Ergonomics, 38(2), 127-134.
  39. Ghosh, R., Siddarth, M., Singh, N., Tyagi, V., Kare, P. K., Banerjee, B. D., ... & Tripathi, A. K. (2017). Organochlorine pesticide level in patients with chronic kidney disease of unknown etiology and its association with renal function. Environmental health and preventive medicine, 22(1), 49.
  40. Sanoff, S. L., Callejas, L., Alonso, C. D., Hu, Y., Colindres, R. E., Chin, H., ... & Hogan, S. L. (2010). Positive association of renal insufficiency with agriculture employment and unregulated alcohol consumption in Nicaragua. Renal failure, 32(7), 766-777.
  41. Laux TS, Bert PJ, Barreto Ruiz GM, González M, Unruh M, Aragon A, Torres Lacourt C (July 2012). "Nicaragua revisited: evidence of lower prevalence of chronic kidney disease in a high-altitude, coffee-growing village". J Nephrol. 25 (4): 533–40. doi:10.5301/jn.5000028. PMC 4405255. PMID 21956767.
  42. Herrera R, Orantes CM, Almaguer M, Alfonso P, Bayarre HD, Leiva IM, Smith MJ, Cubias RA, Torres CG, Almendarez WO, Cubias FR, Morales FE, Magana S, Amaya JC, Perdomo E, Ventura MC, Villatoro JF, Vela XF, Zelaya SM, Granados DV, Vela E, Orellana P, Hevia R, Fuentes EJ, Manalich R, Bacallao R, Ugarte M, Arias MI, Chavez J, Flores NE, Aparicio CE (April 2014). "Clinical characteristics of chronic kidney disease of nontraditional causes in Salvadoran farming communities". MEDICC Rev. 16 (1): 39–48. PMID 24878648.
  43. Yang HY, Hung CC, Liu SH, Guo YG, Chen YC, Ko YC, Huang CT, Chou LF, Tian YC, Chang MY, Hsu HH, Lin MY, Hwang SJ, Yang CW (October 2015). "Overlooked Risk for Chronic Kidney Disease after Leptospiral Infection: A Population-Based Survey and Epidemiological Cohort Evidence". PLOS Neglected Tropical Diseases. 9 (10): e0004105. doi:10.1371/journal.pntd.0004105. PMC 4599860. PMID 26452161.
  44. Murray KO, Fischer RS, Chavarria D, Duttmann C, Garcia MN, Gorchakov R, Hotez PJ, Jiron W, Leibler JH, Lopez JE, Mandayam S, Marin A, Sheleby J (October 2015). "Mesoamerican nephropathy: a neglected tropical disease with an infectious etiology?". Microbes and Infection. 17 (10): 671–75. doi:10.1016/j.micinf.2015.08.005. PMID 26320026.
  45. Declaración de San Salvador. Abordaje integral de la enfermedad renal túbulo-intersticial crónica de Centroamérica (ERTCC) que afecta predominantemente a las comunidades agrícolas. Available in: "Archived copy" (PDF). Archived from the original (PDF) on 2013-09-19. Retrieved 2014-04-04.CS1 maint: archived copy as title (link) Accessed March 2, 2014.
  46. Pan American Health Organization. Resolution CD52.R1. Chronic kidney disease in agricultural communities in Central America. Washington, DC. 2013. Available at: http://www.paho.org/hq/index.php?option=com_content&view=article&id=8833&Itemid=40033&lang=en Accessed June 13, 2013
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.